HPV Vaccine In The News!!!!

Published in The Lancet, an important new study demonstrates that vaccines against the human papillomavirus (HPV) are in fact decreasing HPV infections including precancerous cervical lesions and anogenital warts. This study indicates that the HPV vaccine has been more effective than expected, reducing rates of HPV infection in the vaccinated population and FURTHERMORE reducing rates of HPV-related diseases in the non-vaccinated population (herd immunity). 

In June 2019, the Centers for Disease Control and Prevention's Advisory Committee on Immunization Practices  approved the use of the HPV vaccine in some people through the age of 45. By expanding the pool of approved people, more insurance providers may cover the vaccine. 

For more information and news on the HPV vaccine: